Submitted by christian on Tue, 07/12/2022 - 16:44
Pharmaceutical goods infringing IP rights are a substantial threat to the EU and affect most, if not all, Member States. The trade in counterfeit pharmaceutical products in the EU has been increasing over recent years. The number of counterfeit medicines and other goods seized by EU customs authorities reached 1 172 076 units in 2019, entering the top 10 list of seized products by number of articles. The trend was confirmed in 2020, with medicines appearing as the seventh most-seized products at the EU’s external border.
